Rank | Gene Set | Z-score |
---|---|---|
1 | epithelial structure maintenance (GO:0010669) | 9.96159277 |
2 | surfactant homeostasis (GO:0043129) | 9.94433496 |
3 | intestinal cholesterol absorption (GO:0030299) | 8.20067165 |
4 | chemical homeostasis within a tissue (GO:0048875) | 7.95381935 |
5 | neutrophil mediated immunity (GO:0002446) | 7.90577660 |
6 | * digestion (GO:0007586) | 7.90200603 |
7 | pH reduction (GO:0045851) | 7.45983830 |
8 | extracellular fibril organization (GO:0043206) | 7.34492872 |
9 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 6.90570368 |
10 | leukotriene biosynthetic process (GO:0019370) | 6.60419992 |
11 | digestive system process (GO:0022600) | 6.57423401 |
12 | protein autoprocessing (GO:0016540) | 6.54844558 |
13 | arachidonic acid secretion (GO:0050482) | 6.44953873 |
14 | icosanoid secretion (GO:0032309) | 6.44953873 |
15 | cobalamin metabolic process (GO:0009235) | 6.40641349 |
16 | sulfation (GO:0051923) | 6.39357227 |
17 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 6.27069237 |
18 | negative regulation of fibrinolysis (GO:0051918) | 6.26109060 |
19 | regulation of complement activation (GO:0030449) | 6.25896396 |
20 | fibril organization (GO:0097435) | 6.22307406 |
21 | regulation of protein activation cascade (GO:2000257) | 6.19672336 |
22 | glutathione derivative biosynthetic process (GO:1901687) | 6.18464973 |
23 | glutathione derivative metabolic process (GO:1901685) | 6.18464973 |
24 | myeloid leukocyte mediated immunity (GO:0002444) | 6.17846050 |
25 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.01432794 |
26 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 6.00855926 |
27 | O-glycan processing (GO:0016266) | 5.95903270 |
28 | fatty acid derivative transport (GO:1901571) | 5.84792257 |
29 | icosanoid transport (GO:0071715) | 5.84792257 |
30 | regulation of apoptotic cell clearance (GO:2000425) | 5.76141753 |
31 | regulation of pH (GO:0006885) | 5.73824630 |
32 | negative regulation of protein activation cascade (GO:2000258) | 5.71251245 |
33 | low-density lipoprotein particle remodeling (GO:0034374) | 5.66558944 |
34 | protein retention in ER lumen (GO:0006621) | 5.48329986 |
35 | complement activation, classical pathway (GO:0006958) | 5.44187549 |
36 | leukotriene metabolic process (GO:0006691) | 5.38623702 |
37 | plasma lipoprotein particle assembly (GO:0034377) | 5.37470234 |
38 | growth hormone secretion (GO:0030252) | 5.37356529 |
39 | negative regulation of complement activation (GO:0045916) | 5.34348740 |
40 | antibacterial humoral response (GO:0019731) | 5.28615385 |
41 | phosphatidylserine metabolic process (GO:0006658) | 5.27851686 |
42 | intestinal absorption (GO:0050892) | 5.26667769 |
43 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.26516819 |
44 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.26516819 |
45 | regulation of fibrinolysis (GO:0051917) | 5.13529026 |
46 | innate immune response in mucosa (GO:0002227) | 5.11998357 |
47 | vitamin transport (GO:0051180) | 5.09565969 |
48 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.05172568 |
49 | doxorubicin metabolic process (GO:0044598) | 5.01136369 |
50 | daunorubicin metabolic process (GO:0044597) | 5.01136369 |
51 | polyketide metabolic process (GO:0030638) | 5.01136369 |
52 | antimicrobial humoral response (GO:0019730) | 4.96311995 |
53 | complement activation (GO:0006956) | 4.94177232 |
54 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.91050241 |
55 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.91050241 |
56 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.89702713 |
57 | protein activation cascade (GO:0072376) | 4.86595960 |
58 | protein-lipid complex assembly (GO:0065005) | 4.80043253 |
59 | positive regulation of growth hormone secretion (GO:0060124) | 4.75882714 |
60 | acid secretion (GO:0046717) | 4.74956800 |
61 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.73712566 |
62 | protein carboxylation (GO:0018214) | 4.73712566 |
63 | regulation of cholesterol homeostasis (GO:2000188) | 4.71581394 |
64 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.58331565 |
65 | thyroid hormone metabolic process (GO:0042403) | 4.57132276 |
66 | regulation of cholesterol esterification (GO:0010872) | 4.46942776 |
67 | blood coagulation, intrinsic pathway (GO:0007597) | 4.46044684 |
68 | diacylglycerol metabolic process (GO:0046339) | 4.42373882 |
69 | thyroid hormone generation (GO:0006590) | 4.42326213 |
70 | plasma lipoprotein particle remodeling (GO:0034369) | 4.41442041 |
71 | protein-lipid complex remodeling (GO:0034368) | 4.41442041 |
72 | macromolecular complex remodeling (GO:0034367) | 4.41442041 |
73 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.40791381 |
74 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.33564746 |
75 | peptidyl-proline hydroxylation (GO:0019511) | 4.32923598 |
76 | protein O-linked glycosylation (GO:0006493) | 4.32685695 |
77 | low-density lipoprotein particle clearance (GO:0034383) | 4.28484361 |
78 | negative regulation of humoral immune response (GO:0002921) | 4.25739162 |
79 | negative regulation of interleukin-1 beta production (GO:0032691) | 4.25621113 |
80 | alditol phosphate metabolic process (GO:0052646) | 4.24639794 |
81 | plasma lipoprotein particle organization (GO:0071827) | 4.23284362 |
82 | cholesterol efflux (GO:0033344) | 4.20208322 |
83 | mucosal immune response (GO:0002385) | 4.12856028 |
84 | ATP biosynthetic process (GO:0006754) | 4.09973458 |
85 | plasma lipoprotein particle clearance (GO:0034381) | 4.09368837 |
86 | positive regulation of extracellular matrix organization (GO:1903055) | 4.06476154 |
87 | protein-lipid complex subunit organization (GO:0071825) | 3.98880910 |
88 | negative regulation of interleukin-1 production (GO:0032692) | 3.97702153 |
89 | response to iron ion (GO:0010039) | 3.94689926 |
90 | progesterone metabolic process (GO:0042448) | 3.92192460 |
91 | ethanol oxidation (GO:0006069) | 3.90241868 |
92 | organ or tissue specific immune response (GO:0002251) | 3.89613717 |
93 | hydrogen ion transmembrane transport (GO:1902600) | 3.87800281 |
94 | negative regulation of digestive system process (GO:0060457) | 3.80914653 |
95 | trivalent inorganic anion homeostasis (GO:0072506) | 3.80220878 |
96 | phosphate ion homeostasis (GO:0055062) | 3.80220878 |
97 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.78550909 |
98 | monovalent inorganic cation homeostasis (GO:0055067) | 3.75249940 |
99 | complement activation, alternative pathway (GO:0006957) | 3.75081262 |
100 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.73550728 |
101 | regulation of plasminogen activation (GO:0010755) | 3.73273725 |
102 | retinal metabolic process (GO:0042574) | 3.71510513 |
103 | regulation of humoral immune response (GO:0002920) | 3.66404842 |
104 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.65967573 |
105 | L-phenylalanine metabolic process (GO:0006558) | 3.62841453 |
106 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.62841453 |
107 | phospholipid scrambling (GO:0017121) | 3.62279169 |
108 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.59283690 |
109 | L-phenylalanine catabolic process (GO:0006559) | 3.59283690 |
110 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.57591827 |
111 | C21-steroid hormone metabolic process (GO:0008207) | 3.53148300 |
112 | cellular response to nitric oxide (GO:0071732) | 3.51833493 |
113 | phosphatidic acid biosynthetic process (GO:0006654) | 3.51395985 |
114 | phosphatidic acid metabolic process (GO:0046473) | 3.51395985 |
115 | fucose catabolic process (GO:0019317) | 3.48901453 |
116 | L-fucose metabolic process (GO:0042354) | 3.48901453 |
117 | L-fucose catabolic process (GO:0042355) | 3.48901453 |
118 | sterol transport (GO:0015918) | 3.48328608 |
119 | cholesterol transport (GO:0030301) | 3.48328608 |
120 | valine metabolic process (GO:0006573) | 3.44914343 |
121 | protein hydroxylation (GO:0018126) | 3.43189106 |
122 | adult feeding behavior (GO:0008343) | 3.41404574 |
123 | regulation of growth hormone secretion (GO:0060123) | 3.40791635 |
124 | cholesterol homeostasis (GO:0042632) | 3.40461897 |
125 | renal absorption (GO:0070293) | 3.39144026 |
126 | regulation of extracellular matrix organization (GO:1903053) | 3.38786362 |
127 | high-density lipoprotein particle remodeling (GO:0034375) | 3.38452747 |
128 | regulation of bile acid biosynthetic process (GO:0070857) | 3.37392375 |
129 | sterol homeostasis (GO:0055092) | 3.37329553 |
130 | lipoprotein metabolic process (GO:0042157) | 3.35166414 |
131 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.34075767 |
132 | ethanol metabolic process (GO:0006067) | 3.32315328 |
133 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.30297962 |
134 | negative regulation of sterol transport (GO:0032372) | 3.30133439 |
135 | negative regulation of cholesterol transport (GO:0032375) | 3.30133439 |
136 | regulation of glucocorticoid secretion (GO:2000849) | 3.28078162 |
137 | proton transport (GO:0015992) | 3.27307447 |
138 | sodium ion export (GO:0071436) | 3.26063525 |
139 | endocrine hormone secretion (GO:0060986) | 3.24552510 |
140 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.24515921 |
141 | hydrogen transport (GO:0006818) | 3.22389642 |
142 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.21581118 |
143 | branched-chain amino acid catabolic process (GO:0009083) | 3.20488352 |
144 | acute-phase response (GO:0006953) | 3.17805862 |
145 | sulfur amino acid catabolic process (GO:0000098) | 3.16988996 |
146 | cellular response to gonadotropin stimulus (GO:0071371) | 3.15262247 |
147 | xenobiotic metabolic process (GO:0006805) | 3.12884468 |
148 | cellular anion homeostasis (GO:0030002) | 3.12077562 |
149 | positive regulation of phagocytosis (GO:0050766) | 3.11537607 |
150 | pinocytosis (GO:0006907) | 3.10531572 |
151 | glutathione metabolic process (GO:0006749) | 3.09520496 |
152 | positive regulation of chemokine secretion (GO:0090197) | 3.08366970 |
153 | phosphatidylglycerol metabolic process (GO:0046471) | 3.07403280 |
154 | reverse cholesterol transport (GO:0043691) | 3.06229018 |
155 | production of molecular mediator of immune response (GO:0002440) | 3.06068502 |
156 | peptide catabolic process (GO:0043171) | 3.05233841 |
157 | positive regulation of hemostasis (GO:1900048) | 3.04267209 |
158 | positive regulation of blood coagulation (GO:0030194) | 3.04267209 |
159 | glandular epithelial cell differentiation (GO:0002067) | 3.03096960 |
160 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.01033839 |
161 | cellular response to reactive nitrogen species (GO:1902170) | 2.95358930 |
162 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.94280366 |
163 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.93583003 |
164 | cellular response to arsenic-containing substance (GO:0071243) | 2.93352043 |
165 | long-chain fatty acid transport (GO:0015909) | 2.93105793 |
166 | kidney morphogenesis (GO:0060993) | 2.91961419 |
167 | membrane repolarization during action potential (GO:0086011) | 2.91289916 |
168 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.90105435 |
169 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.89596937 |
170 | bicarbonate transport (GO:0015701) | 2.89394697 |
171 | intestinal epithelial cell development (GO:0060576) | 2.89364672 |
172 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.88551784 |
173 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.88551784 |
174 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.88510435 |
175 | glycerol metabolic process (GO:0006071) | 2.88459519 |
176 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.88100866 |
177 | transepithelial transport (GO:0070633) | 2.87557750 |
178 | response to vitamin A (GO:0033189) | 2.87065436 |
179 | cellular hyperosmotic response (GO:0071474) | 2.85953830 |
180 | L-serine transport (GO:0015825) | 2.85625124 |
181 | regulation of skeletal muscle contraction (GO:0014819) | 2.85342216 |
182 | positive regulation of coagulation (GO:0050820) | 2.83634171 |
183 | regulation of cholesterol storage (GO:0010885) | 2.82865914 |
184 | regulation of cholesterol metabolic process (GO:0090181) | 2.81130892 |
185 | negative regulation of hemostasis (GO:1900047) | 2.80941894 |
186 | negative regulation of blood coagulation (GO:0030195) | 2.80941894 |
187 | lung secretory cell differentiation (GO:0061140) | 2.80697378 |
188 | response to prostaglandin (GO:0034694) | 2.80286371 |
189 | positive regulation of lipid storage (GO:0010884) | 2.80061908 |
190 | regulation of chemokine secretion (GO:0090196) | 2.79930021 |
191 | cell proliferation involved in metanephros development (GO:0072203) | 2.76652242 |
192 | lipid homeostasis (GO:0055088) | 2.74275398 |
193 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.72960384 |
194 | regulation of metalloenzyme activity (GO:0048552) | 2.71331363 |
195 | maintenance of gastrointestinal epithelium (GO:0030277) | 13.0825536 |
196 | regulation of phospholipase A2 activity (GO:0032429) | 11.6099239 |
197 | regulation of proton transport (GO:0010155) | 11.4038111 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 5.59321420 |
2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 5.36104438 |
3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 5.22496627 |
4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.71047754 |
5 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 3.23859689 |
6 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.22709526 |
7 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.19052401 |
8 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.19052401 |
9 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.19052401 |
10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.18506168 |
11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.02393250 |
12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.00733192 |
13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.99011527 |
14 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.75251248 |
15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.66327619 |
16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.51042083 |
17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.40480637 |
18 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.39065377 |
19 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.37571269 |
20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.19843925 |
21 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.06023012 |
22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.05873694 |
23 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.05598767 |
24 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.00049669 |
25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.98952960 |
26 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.98039608 |
27 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.97686453 |
28 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.96989608 |
29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.94638913 |
30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93413788 |
31 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.91211165 |
32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86427266 |
33 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.86098540 |
34 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83942603 |
35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83483089 |
36 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.82559734 |
37 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.63604248 |
38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.58064193 |
39 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.57488309 |
40 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.54402362 |
41 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.54104439 |
42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.53356933 |
43 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.53228444 |
44 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.52576726 |
45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.45191891 |
46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44025831 |
47 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43284366 |
48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40669776 |
49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40128118 |
50 | * EGR1_19032775_ChIP-ChIP_M12_Human | 1.36341365 |
51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34688731 |
52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33868173 |
53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33742112 |
54 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.31480702 |
55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29177195 |
56 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28023168 |
57 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27470909 |
58 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.26855868 |
59 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25665175 |
60 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25336789 |
61 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24627125 |
62 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.24490342 |
63 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.22630605 |
64 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.19837530 |
65 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.19177597 |
66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18751592 |
67 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.18424618 |
68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17453208 |
69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.17346971 |
70 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17230539 |
71 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.17014871 |
72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14709996 |
73 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.14252179 |
74 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13371792 |
75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12877030 |
76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12575454 |
77 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12495137 |
78 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12186420 |
79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11087671 |
80 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07681136 |
81 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06963699 |
82 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06700077 |
83 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05874928 |
84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05236049 |
85 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.04616917 |
86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03498489 |
87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02872352 |
88 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00844556 |
89 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00294013 |
90 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98644052 |
91 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96401770 |
92 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95706802 |
93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95706802 |
94 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94025531 |
95 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.93165803 |
96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92209242 |
97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91691351 |
98 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.91222512 |
99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.91222512 |
100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.91201988 |
101 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.90706538 |
102 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90284421 |
103 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.88764705 |
104 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87193228 |
105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86667501 |
106 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86544492 |
107 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86379573 |
108 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.86344545 |
109 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86005006 |
110 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.85826006 |
111 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85415552 |
112 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.85325430 |
113 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85131626 |
114 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84770301 |
115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84329740 |
116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84249506 |
117 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82498091 |
118 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.82450908 |
119 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82072463 |
120 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81211440 |
121 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.80635024 |
122 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79953411 |
123 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.79720332 |
124 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.79520980 |
125 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.78829365 |
126 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.78762656 |
127 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.78584032 |
128 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78305565 |
129 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.78204131 |
130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77890526 |
131 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.77860893 |
132 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.77547693 |
133 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77314802 |
134 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77108285 |
135 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.76380064 |
136 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76145006 |
137 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.75851611 |
138 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.74276271 |
139 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.73698027 |
140 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.73142445 |
141 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.73109481 |
142 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.71688371 |
143 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.71339133 |
144 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.69595331 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004782_abnormal_surfactant_physiolog | 6.01092835 |
2 | MP0001664_abnormal_digestion | 5.06126743 |
3 | MP0000470_abnormal_stomach_morphology | 4.35184672 |
4 | MP0001873_stomach_inflammation | 4.09955610 |
5 | MP0001666_abnormal_nutrient_absorption | 3.73457751 |
6 | MP0001958_emphysema | 3.52332832 |
7 | MP0003122_maternal_imprinting | 3.35752484 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.04882221 |
9 | MP0003195_calcinosis | 2.60135273 |
10 | MP0005083_abnormal_biliary_tract | 2.38041281 |
11 | MP0005058_abnormal_lysosome_morphology | 2.34674181 |
12 | MP0003868_abnormal_feces_composition | 2.23089762 |
13 | MP0002089_abnormal_postnatal_growth/wei | 2.18207647 |
14 | MP0010368_abnormal_lymphatic_system | 2.05328977 |
15 | MP0004272_abnormal_basement_membrane | 2.04506044 |
16 | MP0008004_abnormal_stomach_pH | 17.6576236 |
17 | MP0005167_abnormal_blood-brain_barrier | 1.83743154 |
18 | MP0005451_abnormal_body_composition | 1.83097969 |
19 | MP0005164_abnormal_response_to | 1.72239503 |
20 | MP0002133_abnormal_respiratory_system | 1.67289991 |
21 | MP0005388_respiratory_system_phenotype | 1.67289991 |
22 | MP0005409_darkened_coat_color | 1.66861850 |
23 | MP0004883_abnormal_blood_vessel | 1.58675293 |
24 | MP0003123_paternal_imprinting | 1.58277439 |
25 | MP0005165_increased_susceptibility_to | 1.58106615 |
26 | MP0001663_abnormal_digestive_system | 1.55757085 |
27 | MP0000566_synostosis | 1.54301998 |
28 | MP0010234_abnormal_vibrissa_follicle | 1.51981355 |
29 | MP0008995_early_reproductive_senescence | 1.49826606 |
30 | MP0005085_abnormal_gallbladder_physiolo | 1.49031331 |
31 | MP0003950_abnormal_plasma_membrane | 1.40172391 |
32 | MP0005381_digestive/alimentary_phenotyp | 1.39307641 |
33 | MP0003172_abnormal_lysosome_physiology | 1.33817917 |
34 | MP0001915_intracranial_hemorrhage | 1.31534373 |
35 | MP0002295_abnormal_pulmonary_circulatio | 1.22938666 |
36 | MP0003115_abnormal_respiratory_system | 1.21364881 |
37 | MP0001661_extended_life_span | 1.18528789 |
38 | MP0002132_abnormal_respiratory_system | 1.17803157 |
39 | MP0002971_abnormal_brown_adipose | 1.14511982 |
40 | MP0003091_abnormal_cell_migration | 1.13397183 |
41 | MP0002933_joint_inflammation | 1.13033811 |
42 | MP0001177_atelectasis | 1.09610037 |
43 | MP0010329_abnormal_lipoprotein_level | 1.09040240 |
44 | MP0002909_abnormal_adrenal_gland | 1.04057536 |
45 | MP0004264_abnormal_extraembryonic_tissu | 1.03526165 |
46 | MP0005076_abnormal_cell_differentiation | 1.03461093 |
47 | MP0006138_congestive_heart_failure | 1.01980368 |
48 | MP0000249_abnormal_blood_vessel | 1.01232658 |
49 | MP0006054_spinal_hemorrhage | 1.00880639 |
50 | MP0002166_altered_tumor_susceptibility | 1.00213891 |
51 | MP0005023_abnormal_wound_healing | 0.99440473 |
52 | MP0008875_abnormal_xenobiotic_pharmacok | 0.98273629 |
53 | MP0005365_abnormal_bile_salt | 0.97190204 |
54 | MP0000477_abnormal_intestine_morphology | 0.97134715 |
55 | MP0001851_eye_inflammation | 0.95824810 |
56 | MP0003724_increased_susceptibility_to | 0.95079751 |
57 | MP0003705_abnormal_hypodermis_morpholog | 0.87155016 |
58 | MP0002998_abnormal_bone_remodeling | 0.85926869 |
59 | MP0003186_abnormal_redox_activity | 0.84163525 |
60 | MP0005464_abnormal_platelet_physiology | 0.82035952 |
61 | MP0009115_abnormal_fat_cell | 0.81623766 |
62 | MP0001175_abnormal_lung_morphology | 0.80791543 |
63 | MP0001270_distended_abdomen | 0.78786267 |
64 | MP0003283_abnormal_digestive_organ | 0.78587491 |
65 | MP0005266_abnormal_metabolism | 0.77374950 |
66 | MP0003890_abnormal_embryonic-extraembry | 0.77093770 |
67 | MP0009384_cardiac_valve_regurgitation | 0.76656171 |
68 | MP0000767_abnormal_smooth_muscle | 0.75025367 |
69 | MP0005448_abnormal_energy_balance | 0.72451888 |
70 | MP0003941_abnormal_skin_development | 0.72438344 |
71 | MP0005666_abnormal_adipose_tissue | 0.71125029 |
72 | MP0000462_abnormal_digestive_system | 0.70294492 |
73 | MP0001542_abnormal_bone_strength | 0.70239268 |
74 | MP0002118_abnormal_lipid_homeostasis | 0.66380203 |
75 | MP0002128_abnormal_blood_circulation | 0.65469763 |
76 | MP0008469_abnormal_protein_level | 0.65359695 |
77 | MP0002876_abnormal_thyroid_physiology | 0.65312932 |
78 | MP0003436_decreased_susceptibility_to | 0.65237838 |
79 | MP0000003_abnormal_adipose_tissue | 0.63573594 |
80 | MP0005084_abnormal_gallbladder_morpholo | 0.63501776 |
81 | MP0003942_abnormal_urinary_system | 0.63288192 |
82 | MP0002837_dystrophic_cardiac_calcinosis | 0.62854485 |
83 | MP0005670_abnormal_white_adipose | 0.62672570 |
84 | MP0000467_abnormal_esophagus_morphology | 0.61507294 |
85 | MP0005257_abnormal_intraocular_pressure | 0.61345633 |
86 | MP0004484_altered_response_of | 0.60360509 |
87 | MP0000537_abnormal_urethra_morphology | 0.59325672 |
88 | MP0003953_abnormal_hormone_level | 0.58197660 |
89 | MP0002139_abnormal_hepatobiliary_system | 0.58056071 |
90 | MP0003075_altered_response_to | 0.57369288 |
91 | MP0004185_abnormal_adipocyte_glucose | 0.57257243 |
92 | MP0002970_abnormal_white_adipose | 0.53123176 |
93 | MP0000490_abnormal_crypts_of | 0.50710693 |
94 | MP0003191_abnormal_cellular_cholesterol | 0.49578652 |
95 | MP0002796_impaired_skin_barrier | 0.48655937 |
96 | MP0005452_abnormal_adipose_tissue | 0.47744938 |
97 | MP0004858_abnormal_nervous_system | 0.47177997 |
98 | MP0001243_abnormal_dermal_layer | 0.46998675 |
99 | MP0004130_abnormal_muscle_cell | 0.42797607 |
100 | MP0003566_abnormal_cell_adhesion | 0.41216545 |
101 | MP0002078_abnormal_glucose_homeostasis | 0.41040684 |
102 | MP0005334_abnormal_fat_pad | 0.39886093 |
103 | MP0010155_abnormal_intestine_physiology | 0.39043490 |
104 | MP0005166_decreased_susceptibility_to | 0.38649832 |
105 | MP0005360_urolithiasis | 0.35597156 |
106 | MP0009642_abnormal_blood_homeostasis | 0.35244284 |
107 | MP0003329_amyloid_beta_deposits | 0.35053801 |
108 | MP0004947_skin_inflammation | 0.33841891 |
109 | MP0005319_abnormal_enzyme/_coenzyme | 0.33211431 |
110 | MP0004859_abnormal_synaptic_plasticity | 0.31902148 |
111 | MP0005376_homeostasis/metabolism_phenot | 0.30467221 |
112 | MP0003252_abnormal_bile_duct | 0.29699044 |
113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.29257037 |
114 | MP0004043_abnormal_pH_regulation | 0.28591448 |
115 | MP0008770_decreased_survivor_rate | 0.27320873 |
116 | MP0000598_abnormal_liver_morphology | 0.27076750 |
117 | MP0003866_abnormal_defecation | 0.26968275 |
118 | MP0000367_abnormal_coat/_hair | 0.26918537 |
119 | MP0000013_abnormal_adipose_tissue | 0.26063444 |
120 | MP0008438_abnormal_cutaneous_collagen | 0.25904443 |
121 | MP0009780_abnormal_chondrocyte_physiolo | 0.25449316 |
122 | MP0010352_gastrointestinal_tract_polyps | 0.23542092 |
123 | MP0003690_abnormal_glial_cell | 0.23057050 |
124 | MP0002234_abnormal_pharynx_morphology | 0.22983983 |
125 | MP0003656_abnormal_erythrocyte_physiolo | 0.22456664 |
126 | MP0004019_abnormal_vitamin_homeostasis | 0.22293061 |
127 | MP0005332_abnormal_amino_acid | 0.22031702 |
128 | MP0001756_abnormal_urination | 0.21868548 |
129 | MP0001216_abnormal_epidermal_layer | 0.21623574 |
130 | MP0000609_abnormal_liver_physiology | 0.21437044 |
131 | MP0002060_abnormal_skin_morphology | 0.21292414 |
132 | MP0009643_abnormal_urine_homeostasis | 0.20539164 |
133 | MP0001440_abnormal_grooming_behavior | 0.20092728 |
134 | MP0002069_abnormal_eating/drinking_beha | 0.19692872 |
135 | MP0001849_ear_inflammation | 0.19582217 |
136 | MP0005310_abnormal_salivary_gland | 0.18606774 |
137 | MP0002877_abnormal_melanocyte_morpholog | 0.18112085 |
138 | MP0000604_amyloidosis | 0.17983365 |
139 | MP0000465_gastrointestinal_hemorrhage | 0.17449436 |
140 | MP0002693_abnormal_pancreas_physiology | 0.16671072 |
141 | MP0005408_hypopigmentation | 0.16497697 |
142 | MP0003221_abnormal_cardiomyocyte_apopto | 0.16452407 |
143 | MP0003119_abnormal_digestive_system | 0.16278610 |
144 | MP0002972_abnormal_cardiac_muscle | 0.15762821 |
145 | MP0009840_abnormal_foam_cell | 0.15756686 |
146 | MP0010678_abnormal_skin_adnexa | 0.15719250 |
147 | MP0001845_abnormal_inflammatory_respons | 0.15457786 |
148 | MP0005636_abnormal_mineral_homeostasis | 0.15443160 |
149 | MP0002019_abnormal_tumor_incidence | 0.14706547 |
150 | MP0003638_abnormal_response/metabolism_ | 0.14608835 |
151 | MP0000343_altered_response_to | 0.14490933 |
152 | MP0003453_abnormal_keratinocyte_physiol | 0.14125251 |
153 | MP0005220_abnormal_exocrine_pancreas | 0.13699798 |
154 | MP0005501_abnormal_skin_physiology | 0.13683387 |
155 | MP0009931_abnormal_skin_appearance | 0.13393002 |
156 | MP0005275_abnormal_skin_tensile | 0.13054391 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Megaloblastic anemia (HP:0001889) | 9.15216531 |
2 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 8.78383715 |
3 | Abnormality of vitamin B metabolism (HP:0004340) | 8.28503536 |
4 | Interstitial pulmonary disease (HP:0006530) | 7.89280336 |
5 | Abnormality of vitamin metabolism (HP:0100508) | 6.81819901 |
6 | Complement deficiency (HP:0004431) | 6.52454089 |
7 | Systemic lupus erythematosus (HP:0002725) | 6.21376032 |
8 | Glomerulonephritis (HP:0000099) | 6.09462285 |
9 | Right ventricular cardiomyopathy (HP:0011663) | 5.83348255 |
10 | Abnormality of complement system (HP:0005339) | 5.29852538 |
11 | Joint hemorrhage (HP:0005261) | 5.04206074 |
12 | Prolonged partial thromboplastin time (HP:0003645) | 4.83601592 |
13 | Gout (HP:0001997) | 4.78622425 |
14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.11367270 |
15 | Ventricular fibrillation (HP:0001663) | 3.92791618 |
16 | Hypobetalipoproteinemia (HP:0003563) | 3.77128028 |
17 | Goiter (HP:0000853) | 3.69668253 |
18 | Abnormal tarsal ossification (HP:0008369) | 3.52025526 |
19 | Macrocytic anemia (HP:0001972) | 3.50771281 |
20 | Nephritis (HP:0000123) | 3.47426019 |
21 | Abnormality of carpal bone ossification (HP:0006257) | 3.46561572 |
22 | Hypercholesterolemia (HP:0003124) | 3.36120233 |
23 | Syncope (HP:0001279) | 3.35158153 |
24 | Tachypnea (HP:0002789) | 3.21673678 |
25 | Small epiphyses (HP:0010585) | 3.21223456 |
26 | Abnormality of the lumbar spine (HP:0100712) | 3.18597252 |
27 | Purpura (HP:0000979) | 3.16176184 |
28 | Mitral stenosis (HP:0001718) | 3.15339468 |
29 | Epidermoid cyst (HP:0200040) | 3.12367878 |
30 | Menorrhagia (HP:0000132) | 3.08064009 |
31 | Spontaneous abortion (HP:0005268) | 2.94193186 |
32 | Myocardial infarction (HP:0001658) | 2.83269205 |
33 | Paresthesia (HP:0003401) | 2.81937024 |
34 | Protrusio acetabuli (HP:0003179) | 2.72250866 |
35 | Hypolipoproteinemia (HP:0010981) | 2.69986341 |
36 | Increased purine levels (HP:0004368) | 2.67728579 |
37 | Hyperuricemia (HP:0002149) | 2.67728579 |
38 | Respiratory distress (HP:0002098) | 2.65961565 |
39 | Palpitations (HP:0001962) | 2.65128115 |
40 | Abnormal ossification of hand bones (HP:0005921) | 2.62712150 |
41 | Acanthocytosis (HP:0001927) | 2.58760316 |
42 | Aortic dissection (HP:0002647) | 2.58299816 |
43 | Fat malabsorption (HP:0002630) | 2.56943255 |
44 | Broad alveolar ridges (HP:0000187) | 2.56863963 |
45 | Abnormal hand bone ossification (HP:0010660) | 2.54786614 |
46 | Ketoacidosis (HP:0001993) | 2.52522774 |
47 | Tubulointerstitial nephritis (HP:0001970) | 2.50464141 |
48 | Malnutrition (HP:0004395) | 2.46613815 |
49 | Broad palm (HP:0001169) | 2.43804871 |
50 | Intrahepatic cholestasis (HP:0001406) | 2.40056093 |
51 | Beaking of vertebral bodies (HP:0004568) | 2.36648912 |
52 | Ketosis (HP:0001946) | 2.36586118 |
53 | Abnormality of purine metabolism (HP:0004352) | 2.35816576 |
54 | Epiphyseal dysplasia (HP:0002656) | 2.35435850 |
55 | Ventricular arrhythmia (HP:0004308) | 2.30890742 |
56 | Abnormal foot bone ossification (HP:0010675) | 2.30699647 |
57 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28189251 |
58 | Mucopolysacchariduria (HP:0008155) | 2.28189251 |
59 | Cerebral aneurysm (HP:0004944) | 2.25678608 |
60 | Neoplasm of the heart (HP:0100544) | 2.22283166 |
61 | Aortic aneurysm (HP:0004942) | 2.22108945 |
62 | Esophageal varix (HP:0002040) | 2.21056296 |
63 | Woolly hair (HP:0002224) | 2.20486740 |
64 | Flared iliac wings (HP:0002869) | 2.20024657 |
65 | Polycythemia (HP:0001901) | 2.19600166 |
66 | Glomerulosclerosis (HP:0000096) | 2.19501359 |
67 | Gingival bleeding (HP:0000225) | 2.16332500 |
68 | Potter facies (HP:0002009) | 2.12105008 |
69 | Facial shape deformation (HP:0011334) | 2.12105008 |
70 | Renal salt wasting (HP:0000127) | 2.12104597 |
71 | Arterial tortuosity (HP:0005116) | 2.08052841 |
72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.07881813 |
73 | Tubulointerstitial fibrosis (HP:0005576) | 2.06551464 |
74 | Thrombophlebitis (HP:0004418) | 2.04551838 |
75 | Prolonged QT interval (HP:0001657) | 2.01799003 |
76 | Abnormality of the acetabulum (HP:0003170) | 2.01769722 |
77 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01626933 |
78 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.01449605 |
79 | Asymmetry of the thorax (HP:0001555) | 2.01055767 |
80 | Abnormality of the intrinsic pathway (HP:0010989) | 2.00233678 |
81 | Abnormal number of erythroid precursors (HP:0012131) | 17.6829214 |
82 | Abnormality of cells of the erythroid lineage (HP:0012130) | 15.7826694 |
83 | Hypophosphatemic rickets (HP:0004912) | 1.99359466 |
84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99166730 |
85 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99166730 |
86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99166730 |
87 | Hepatoblastoma (HP:0002884) | 1.95150994 |
88 | Submucous cleft hard palate (HP:0000176) | 1.95063864 |
89 | Ovoid vertebral bodies (HP:0003300) | 1.93966350 |
90 | Frequent falls (HP:0002359) | 1.93420942 |
91 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.92488172 |
92 | Vertebral arch anomaly (HP:0008438) | 1.91738416 |
93 | Alacrima (HP:0000522) | 1.90914578 |
94 | Abnormality of the nasal septum (HP:0000419) | 1.90216883 |
95 | Rickets (HP:0002748) | 1.86808930 |
96 | Deep venous thrombosis (HP:0002625) | 1.85788145 |
97 | Azoospermia (HP:0000027) | 1.85395477 |
98 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 1.84187967 |
99 | Arthropathy (HP:0003040) | 1.83177268 |
100 | Vascular tortuosity (HP:0004948) | 1.83057887 |
101 | Abnormality of the fingertips (HP:0001211) | 1.82422315 |
102 | Vertebral compression fractures (HP:0002953) | 1.81309329 |
103 | Back pain (HP:0003418) | 1.80495998 |
104 | Hyperammonemia (HP:0001987) | 1.80350378 |
105 | Wide nose (HP:0000445) | 1.79041974 |
106 | Abnormality of the Achilles tendon (HP:0005109) | 1.78619587 |
107 | Limited elbow extension (HP:0001377) | 1.78183152 |
108 | Abnormality of the wing of the ilium (HP:0011867) | 1.77804758 |
109 | Striae distensae (HP:0001065) | 1.76362286 |
110 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.76213600 |
111 | Dysostosis multiplex (HP:0000943) | 1.75021093 |
112 | Joint swelling (HP:0001386) | 1.74675473 |
113 | Peritonitis (HP:0002586) | 1.74298874 |
114 | Juvenile onset (HP:0003621) | 1.72762768 |
115 | Sensorimotor neuropathy (HP:0007141) | 1.72698464 |
116 | Thoracic kyphosis (HP:0002942) | 1.70123324 |
117 | Widely patent fontanelles and sutures (HP:0004492) | 1.69941852 |
118 | Chondrocalcinosis (HP:0000934) | 1.68886784 |
119 | Hyperglycinuria (HP:0003108) | 1.68180866 |
120 | Abnormality of the thoracic spine (HP:0100711) | 1.67433968 |
121 | Pigmentary retinal degeneration (HP:0001146) | 1.65868919 |
122 | Osteomalacia (HP:0002749) | 1.64544315 |
123 | Abnormal cartilage morphology (HP:0002763) | 1.63355587 |
124 | Ventricular tachycardia (HP:0004756) | 1.62960096 |
125 | Hypoglycemic coma (HP:0001325) | 1.60644497 |
126 | Lethargy (HP:0001254) | 1.59854761 |
127 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.59279918 |
128 | Gastrointestinal dysmotility (HP:0002579) | 1.57138514 |
129 | Sudden cardiac death (HP:0001645) | 1.54917616 |
130 | Conjunctival hamartoma (HP:0100780) | 1.53679969 |
131 | Abnormality of the gastric mucosa (HP:0004295) | 1.51684334 |
132 | Aneurysm (HP:0002617) | 1.51368380 |
133 | Hemorrhage of the eye (HP:0011885) | 1.50799223 |
134 | Hyperglycinemia (HP:0002154) | 1.50664903 |
135 | Tubular atrophy (HP:0000092) | 1.50313517 |
136 | Ankyloglossia (HP:0010296) | 1.50291912 |
137 | Turricephaly (HP:0000262) | 1.48625378 |
138 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.47428610 |
139 | Abnormality of glycine metabolism (HP:0010895) | 1.47428610 |
140 | Hypoalphalipoproteinemia (HP:0003233) | 1.46417620 |
141 | Facial diplegia (HP:0001349) | 1.46035105 |
142 | Pancreatitis (HP:0001733) | 1.40787885 |
143 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.40677916 |
144 | Growth hormone excess (HP:0000845) | 1.37572658 |
145 | Vascular calcification (HP:0004934) | 1.36903681 |
146 | Increased variability in muscle fiber diameter (HP:0003557) | 1.35520678 |
147 | Xanthomatosis (HP:0000991) | 1.34206147 |
148 | Abnormality of nucleobase metabolism (HP:0010932) | 1.33354530 |
149 | Curly hair (HP:0002212) | 1.32638517 |
150 | Conjugated hyperbilirubinemia (HP:0002908) | 1.32067367 |
151 | Abnormality of oral frenula (HP:0000190) | 1.31204440 |
152 | Aortic regurgitation (HP:0001659) | 1.30829680 |
153 | Spastic diplegia (HP:0001264) | 1.30151997 |
154 | Seborrheic dermatitis (HP:0001051) | 1.29465856 |
155 | Cardiovascular calcification (HP:0011915) | 1.28909868 |
156 | Macroglossia (HP:0000158) | 1.28845689 |
157 | Testicular neoplasm (HP:0010788) | 1.27858092 |
158 | Abnormality of the renal cortex (HP:0011035) | 1.24878301 |
159 | Abdominal situs inversus (HP:0003363) | 1.24835059 |
160 | Abnormality of abdominal situs (HP:0011620) | 1.24835059 |
161 | Scapular winging (HP:0003691) | 1.23796248 |
162 | Cerebral hemorrhage (HP:0001342) | 1.22066160 |
163 | Hyperglycemia (HP:0003074) | 1.20610384 |
164 | Broad metatarsal (HP:0001783) | 1.20108416 |
165 | Stroke (HP:0001297) | 1.18964185 |
166 | Amyloidosis (HP:0011034) | 1.18376972 |
167 | Flat acetabular roof (HP:0003180) | 1.18339415 |
168 | Pheochromocytoma (HP:0002666) | 1.18266526 |
169 | Hyperparathyroidism (HP:0000843) | 1.17761382 |
170 | Atrophic scars (HP:0001075) | 1.17417689 |
171 | Hypotension (HP:0002615) | 1.15944103 |
172 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.15054706 |
173 | Abnormal EKG (HP:0003115) | 1.14808242 |
174 | Skin nodule (HP:0200036) | 1.14466684 |
175 | Dicarboxylic aciduria (HP:0003215) | 1.14318963 |
176 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.14318963 |
177 | Agitation (HP:0000713) | 1.13774965 |
178 | Cupped ribs (HP:0000887) | 1.12737830 |
179 | Pustule (HP:0200039) | 1.12613984 |
180 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.12500640 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FGFR4 | 6.79750681 |
2 | MST4 | 5.92475859 |
3 | MST1R | 5.41612659 |
4 | ERBB4 | 5.25164669 |
5 | FGFR3 | 4.48859977 |
6 | BCKDK | 3.58241114 |
7 | TRIB3 | 3.50111797 |
8 | TGFBR2 | 3.46496028 |
9 | MYLK | 3.34686598 |
10 | EPHA3 | 3.12035176 |
11 | PKN2 | 2.58345885 |
12 | LRRK2 | 2.56257364 |
13 | KSR2 | 2.50019101 |
14 | PIK3CG | 2.40700186 |
15 | MET | 2.21920205 |
16 | LATS1 | 2.21656459 |
17 | CDK12 | 2.17875697 |
18 | RIPK4 | 2.16759757 |
19 | AKT3 | 1.85156661 |
20 | ERN1 | 1.82219804 |
21 | STK10 | 1.77098702 |
22 | MAP3K9 | 1.66339445 |
23 | MAP3K2 | 1.61023037 |
24 | LMTK2 | 1.55599432 |
25 | PAK3 | 1.50482200 |
26 | ZAP70 | 1.44378321 |
27 | PDGFRB | 1.43759400 |
28 | PTK6 | 1.42311158 |
29 | WNK4 | 1.37735916 |
30 | NUAK1 | 1.37383225 |
31 | ROCK2 | 1.31649472 |
32 | STK39 | 1.30309848 |
33 | NLK | 1.26392717 |
34 | FGFR2 | 1.23250561 |
35 | PDK2 | 1.17297286 |
36 | FER | 1.17094026 |
37 | FGFR1 | 1.16811707 |
38 | MAP2K1 | 1.16700201 |
39 | EPHA2 | 1.16651688 |
40 | TTN | 1.15262872 |
41 | TESK1 | 1.12437897 |
42 | DDR2 | 1.08999075 |
43 | PRKCI | 1.04467623 |
44 | MAP3K6 | 1.02369556 |
45 | LATS2 | 1.02239291 |
46 | MAPK11 | 0.99702744 |
47 | PRKG2 | 0.99118520 |
48 | NEK9 | 0.94996246 |
49 | RPS6KA2 | 0.92727993 |
50 | SGK223 | 0.92035590 |
51 | SGK494 | 0.92035590 |
52 | PDK3 | 0.89923518 |
53 | PDK4 | 0.89923518 |
54 | ROCK1 | 0.88598077 |
55 | TYK2 | 0.85948124 |
56 | EPHB1 | 0.84104991 |
57 | MAP2K2 | 0.83908960 |
58 | NEK1 | 0.83738757 |
59 | IRAK1 | 0.82832392 |
60 | SGK3 | 0.80133650 |
61 | PAK2 | 0.79083978 |
62 | NME1 | 0.78254685 |
63 | ICK | 0.77129623 |
64 | RIPK1 | 0.77022459 |
65 | SGK2 | 0.75717339 |
66 | PDPK1 | 0.75051346 |
67 | PAK6 | 0.72699056 |
68 | EEF2K | 0.72084259 |
69 | CAMK1D | 0.71648407 |
70 | MAPKAPK3 | 0.70277843 |
71 | MARK2 | 0.69034726 |
72 | TIE1 | 0.68885355 |
73 | FYN | 0.68594358 |
74 | JAK1 | 0.67008248 |
75 | DYRK1B | 0.65328837 |
76 | STK38L | 0.65244727 |
77 | LIMK1 | 0.64752109 |
78 | CDK6 | 0.63224328 |
79 | PAK4 | 0.62952357 |
80 | PTK2 | 0.62947265 |
81 | MAP3K8 | 0.62843010 |
82 | FRK | 0.62512057 |
83 | PRPF4B | 0.62409289 |
84 | CDC42BPA | 0.61629734 |
85 | NTRK1 | 0.59391293 |
86 | GRK6 | 0.57435449 |
87 | PDK1 | 0.57328895 |
88 | DMPK | 0.56813706 |
89 | RET | 0.55538780 |
90 | MAP2K3 | 0.53359119 |
91 | MAP2K6 | 0.53358184 |
92 | MATK | 0.52775842 |
93 | BCR | 0.51751232 |
94 | EIF2AK1 | 0.51071098 |
95 | DAPK3 | 0.49516031 |
96 | KSR1 | 0.48784002 |
97 | EGFR | 0.48479288 |
98 | RPS6KC1 | 0.48369902 |
99 | RPS6KL1 | 0.48369902 |
100 | MTOR | 0.48075894 |
101 | MELK | 0.47600258 |
102 | BMX | 0.46818321 |
103 | PIK3CA | 0.46774447 |
104 | MINK1 | 0.46620153 |
105 | GSK3A | 0.45111414 |
106 | PHKG2 | 0.44504009 |
107 | PHKG1 | 0.44504009 |
108 | PDGFRA | 0.42926803 |
109 | IGF1R | 0.42549704 |
110 | IRAK3 | 0.42434319 |
111 | SRC | 0.42410446 |
112 | WNK1 | 0.41867079 |
113 | SIK1 | 0.41657844 |
114 | MAP3K7 | 0.41256252 |
115 | RPS6KB2 | 0.40392569 |
116 | TYRO3 | 0.40378002 |
117 | RAF1 | 0.39416217 |
118 | CSK | 0.38001003 |
119 | JAK2 | 0.37746151 |
120 | SGK1 | 0.36815766 |
121 | PAK1 | 0.36495397 |
122 | PRKACG | 0.36197297 |
123 | CAMKK1 | 0.36159510 |
124 | MAP3K5 | 0.35812640 |
125 | RPS6KA6 | 0.35253491 |
126 | HIPK2 | 0.34456021 |
127 | TAOK1 | 0.34019075 |
128 | PBK | 0.33427205 |
129 | MAPKAPK2 | 0.33314985 |
130 | RPS6KB1 | 0.32386513 |
131 | YES1 | 0.32004448 |
132 | SMG1 | 0.30737233 |
133 | PRKAA2 | 0.30376050 |
134 | CDK19 | 0.30103248 |
135 | OXSR1 | 0.29944785 |
136 | ERBB2 | 0.29558286 |
137 | MAPK3 | 0.28812115 |
138 | PRKAA1 | 0.28186426 |
139 | MAP2K4 | 0.27965120 |
140 | ILK | 0.27608259 |
141 | MAP3K13 | 0.27249255 |
142 | STK38 | 0.26901244 |
143 | MAP3K14 | 0.26319322 |
144 | ALK | 0.26016600 |
145 | PTK2B | 0.25292260 |
146 | INSR | 0.25288412 |
147 | PRKD1 | 0.24971247 |
148 | RPS6KA1 | 0.24886540 |
149 | FGR | 0.24431997 |
150 | CDK5 | 0.24143201 |
151 | CAMK2B | 0.22415808 |
152 | MAP3K1 | 0.21953640 |
153 | CAMK2G | 0.21153010 |
154 | MAP3K3 | 0.20846871 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 7.72725811 |
2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 5.45545262 |
3 | Gastric acid secretion_Homo sapiens_hsa04971 | 5.31533307 |
4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.17034703 |
5 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.96810063 |
6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.61315426 |
7 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.17489195 |
8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.03318264 |
9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.00243738 |
10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.97794140 |
11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.71475331 |
12 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.64615192 |
13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.59494513 |
14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.26583495 |
15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.22293818 |
16 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.19181814 |
17 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.15384738 |
18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.00225757 |
19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.90855700 |
20 | Pertussis_Homo sapiens_hsa05133 | 1.83737782 |
21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.79154266 |
22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.69861824 |
23 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.69715064 |
24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.58688166 |
25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.55195090 |
26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52590815 |
27 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.29765685 |
28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29274982 |
29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21398963 |
30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19482174 |
31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19423281 |
32 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.12599261 |
33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10236365 |
34 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.08088490 |
35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.08039903 |
36 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.07015696 |
37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06602336 |
38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.05031348 |
39 | Retinol metabolism_Homo sapiens_hsa00830 | 0.98034664 |
40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95873991 |
41 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.90929026 |
42 | Bile secretion_Homo sapiens_hsa04976 | 0.90193685 |
43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.89950871 |
44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.89939705 |
45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89270077 |
46 | Prion diseases_Homo sapiens_hsa05020 | 0.85975634 |
47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84461064 |
48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83992400 |
49 | Adherens junction_Homo sapiens_hsa04520 | 0.83468318 |
50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81698054 |
51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76566486 |
52 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76241015 |
53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.76200667 |
54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.73907128 |
55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72052860 |
56 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69835180 |
57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69250311 |
58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68457069 |
59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66710989 |
60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66333022 |
61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.65081973 |
62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63768047 |
63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62291615 |
64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61162736 |
65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58562761 |
66 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53838032 |
67 | Mineral absorption_Homo sapiens_hsa04978 | 0.52489685 |
68 | Hepatitis C_Homo sapiens_hsa05160 | 0.51055105 |
69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50230255 |
70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48733709 |
71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46319049 |
72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45032386 |
73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43308137 |
74 | Salivary secretion_Homo sapiens_hsa04970 | 0.42046242 |
75 | Lysine degradation_Homo sapiens_hsa00310 | 0.40673646 |
76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.35566217 |
77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35521490 |
78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34158638 |
79 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33644071 |
80 | Asthma_Homo sapiens_hsa05310 | 0.33164229 |
81 | Tight junction_Homo sapiens_hsa04530 | 0.32685079 |
82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31692547 |
83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31207152 |
84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31048641 |
85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.30646786 |
86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28783112 |
87 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28053880 |
88 | Phagosome_Homo sapiens_hsa04145 | 0.26444698 |
89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.26206324 |
90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.25773788 |
91 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.24937402 |
92 | Lysosome_Homo sapiens_hsa04142 | 0.23677587 |
93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23594487 |
94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.23261722 |
95 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.22213866 |
96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.22101881 |
97 | Amoebiasis_Homo sapiens_hsa05146 | 0.21879891 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21289670 |
99 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21209198 |
100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19079966 |
101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.18876502 |
102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.18429881 |
103 | Peroxisome_Homo sapiens_hsa04146 | 0.18278518 |
104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.18037980 |
105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16868709 |
106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.16774137 |
107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16761938 |
108 | Insulin secretion_Homo sapiens_hsa04911 | 0.16598340 |
109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.16343518 |
110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.12757088 |
111 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.12130628 |
112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.11399282 |
113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.11043323 |
114 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.10775342 |
115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.09842248 |
116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.09716718 |
117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.08792593 |
118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.08710642 |
119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.07921828 |
120 | ABC transporters_Homo sapiens_hsa02010 | 0.06791975 |
121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.06747219 |
122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.06639687 |
123 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.06633472 |
124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.03564525 |
125 | Renin secretion_Homo sapiens_hsa04924 | 0.03401265 |
126 | Alzheimers disease_Homo sapiens_hsa05010 | 0.02817062 |
127 | Sulfur relay system_Homo sapiens_hsa04122 | 0.02705773 |
128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.02655205 |
129 | Bladder cancer_Homo sapiens_hsa05219 | 0.02623037 |
130 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.02514789 |
131 | Insulin resistance_Homo sapiens_hsa04931 | 0.02396905 |
132 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.02099079 |
133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.01737104 |
134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.01724640 |
135 | Gap junction_Homo sapiens_hsa04540 | 0.00751684 |
136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.00439759 |
137 | Focal adhesion_Homo sapiens_hsa04510 | -0.0010805 |
138 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0001209 |